iptheria immunoglobin is a medication used to provide temporary protection against diphtheria, a serious bacterial infection. Here's a closer look at its key characteristics:
What it is:
- A type of immunoglobulin, a protein derived from human blood that contains antibodies (https://www.ncbi.nlm.nih.gov/books/NBK513460/)
- Specifically contains antibodies against the toxin produced by the bacterium Corynebacterium diphtheriae
What it does:
- Provides passive immunity against diphtheria. Passive immunity means the antibodies come from another source (donated blood) and offer immediate, short-term protection.
- The antibodies in diphtheria immunoglobin neutralize the diphtheria toxin, preventing it from damaging tissues and causing illness.
When it's used:
- Primarily used in two situations:
- Exposure prophylaxis: When someone has been exposed to someone with diphtheria but is not fully vaccinated or their vaccination status is unknown.
- Treatment adjunct: In combination with diphtheria antibiotics for people with confirmed or suspected diphtheria infection, especially if they have weak immune systems.
How it's given:
- Diptheria immunoglobin is typically administered by intramuscular injection (into a muscle).
Important to know:
- Diptheria immunoglobin offers short-term protection, usually lasting for a few weeks.
- Vaccination with diphtheria toxoid-containing vaccines (like Td or Tdap) is the recommended way to achieve long-term immunity against diphtheria.
- There can be side effects associated with diphtheria immunoglobin, such as pain or redness at the injection site, fever, chills, or headache.
- It's important to consult a doctor before receiving diphtheria immunoglobin to discuss potential benefits and risks, especially if there are allergies to human blood products.
Additionally:
- Diptheria immunoglobin may not be widely available in some regions.